Related Experiment Video

Updated: Aug 15, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Human pneumocystosis

R Singhal1, B R Mirdha, R Guleria

  • 1Department of Microbiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.

The Indian Journal of Chest Diseases & Allied Sciences
|November 1, 2005
PubMed

Insights

Pneumocystis jiroveci causes pneumonia in immunocompromised individuals, particularly those with acquired immunodeficiency syndrome (AIDS). This review updates on its epidemiology, diagnosis, and prevention.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Immunology

Background:

  • Pneumocystis jiroveci, formerly Pneumocystis carinii, is an opportunistic fungal pathogen.
  • It is a leading cause of pneumonia in immunocompromised individuals, especially those with AIDS.
  • Incidence varies globally, with lower rates reported in developing countries like India.

Purpose of the Study:

  • To provide an updated review of Pneumocystis jiroveci.
  • To focus on epidemiology, taxonomy, diagnostic methods, and prophylaxis.
  • To highlight current understanding and management strategies.

Main Methods:

  • Literature review of recent studies on Pneumocystis jiroveci.
  • Analysis of epidemiological data, taxonomic classifications, and diagnostic techniques.
  • Evaluation of current immuno-prophylaxis recommendations.

Main Results:

  • Pneumocystis jiroveci is the correct species name for the human-derived organism.
  • Microscopy remains a primary diagnostic tool, with amplification techniques under evaluation.
  • Global incidence data shows disparities, with lower prevalence in certain regions.

Conclusions:

  • Accurate identification and understanding of P. jiroveci are crucial for managing opportunistic infections.
  • Advancements in diagnostic and prophylactic strategies are essential for patient care.
  • Continued research is needed to address global health disparities in pneumocystosis.

More Related Videos

Experimental Human Pneumococcal Carriage07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...